Keep your finger on the pulse with the latest local and global trends from our industry experts.
When the UK's transition period with the European Union ends on 31 December 2020, the EU’s Common Tariff Regime is set to be replaced by a new system.
Christian Shiba
5 min read
Recently unveiled reforms to the Superannuation Funds industry are set to deliver better outcomes for consumers, heightening competitive pressure.
5 min read
Dieser Artikel beschäftigt sich mit den Auwirkungen der Coronavirus-Pandemie auf den Einsatz von Robotern in der Pflege und die Telemedizin.
Sabrina Heber
4 min read
With gig workers having been hard hit during the COVID-19 (coronavirus) pandemic, IBISWorld has assessed how this area of the economy is likely to change in the future.
John Griffin
6 min read
Senior Analyst Mario Ismailanji provides a macroeconomic update and a risk outlook, touching on important trends in labour, household spending, construction, among others.
Mario Ismailanji
7 min read
Dieser Artikel beschäftigt sich mit den Möglichkeiten des kontaktlosen Einkaufens in Deutschland und wie sich die Coronakrise darauf auswirkt.
Annemarie Alexander
4 min read
This article provides some insights into the negative effects the COVID-19 pandemic has had on spectator sports operators and convention and visitor bureaus, among other sectors.
Eva Koronios
3 min read
Vitamin and supplements sales and digital marketing across social media has been successful, but could lead to an increase in product-specific regulation due to public scrutiny.
Cecilia Fernandez
3 min read
Lead analyst Jeremy Moses provides an insight into the rise in merger and acquisition activity in the telecommunication sector and its expansion into the prepaid customer market.
Jeremy Moses
2 min read
IBISWorld, Australia’s largest industry research company, has named the Top 500 private companies for 2019-20.
5 min read
IBISWorld examines innovation opportunities for supermarkets, through the use of technology to enhance consumer convenience and in-store experiences.
6 min read
IBISWorld’s pharmaceuticals analyst Dan Spitzer tracks the progress of the COVID-19 vaccine as it enters phase three trials and some challenges the final product could face.
3 min read
If you like our blog and newsletter, we know you’ll love our industry research products.
Talk to us today to learn more about membership.
